HOUSE PANEL SEEKS FDA's DATA ON PROBLEMS AT FLU VACCINE PLANT

Washington Drug Letter
A A

Leaders of a House government panel are seeking documents from the FDA to help shed light on whether the agency knew about problems at vaccine maker Chiron's manufacturing facility in England, which was forced to suspend production of the Fluvirin flu vaccine by the UK's health regulator earlier this month.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00